Molecular diagnostics firm BillionToOne files for US IPO

Core Viewpoint - BillionToOne has filed for an initial public offering (IPO) in the United States, indicating its intention to raise capital through public markets [1] Company Summary - BillionToOne is preparing to enter the public market by filing for an IPO, which suggests a strategic move to enhance its financial position and expand its operations [1]